Cargando…
T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management
Cancer-induced immunosuppression significantly impacts tumors, rendering them the ability to acquire aggressive and treatment-resistant phenotypes. The recent clinical success of drugs targeting the immunosuppressive machinery of tumors highlights the importance of identifying novel drugs that effec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928365/ https://www.ncbi.nlm.nih.gov/pubmed/27471694 http://dx.doi.org/10.2147/ITT.S38296 |